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During inﬂammation, myeloperoxidase (MPO) released by circulating leukocytes accumulates within
the subendothelial matrix by binding to and transcytosing the vascular endothelium. Oxidative
reactions catalyzed by subendothelial-localized MPO are implicated as a cause of endothelial dysfunc-
tion in vascular disease. While the subendothelial matrix is a key target for MPO-derived oxidants
during disease, the implications of this damage for endothelial morphology and signaling are largely
unknown. We found that endothelial-transcytosed MPO produced hypochlorous acid (HOCl) that
reacted locally with the subendothelial matrix and induced covalent cross-linking of the adhesive
matrix protein ﬁbronectin. Real-time biosensor and live cell imaging studies revealed that HOCl-
mediated matrix oxidation triggered rapid membrane retraction from the substratum and adjacent
cells (de-adhesion). De-adhesion was linked with the alteration of Tyr-118 phosphorylation of paxillin,
a key adhesion-dependent signaling process, as well as Rho kinase-dependent myosin light chain-2
phosphorylation. De-adhesion dynamics were dependent on the contractile state of cells, with myosin
II inhibition with blebbistatin attenuating the rate of membrane retraction. Rho kinase inhibition with
Y-27632 also conferred protection, but not during the initial phase of membrane retraction, which was
driven by pre-existing actomyosin tensile stress. Notably, diversion of MPO from HOCl production by
thiocyanate or nitrite attenuated de-adhesion and associated signaling responses, despite the latter
substrate supporting MPO-catalyzed ﬁbronectin nitration. These data show that subendothelial-
localized MPO employs a novel ‘‘outside-in’’ mode of redox signaling, involving HOCl-mediated matrix
oxidation. These MPO-catalyzed oxidative events are likely to play a previously unrecognized role in
altering endothelial integrity and signaling during inﬂammatory vascular disorders.
& 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
The vascular endothelium performs vital functions in cardiovas-
cular homeostasis by regulating the initiation and resolution of2
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to the homeostatic properties of the endothelium is the production
of nitric oxide (NO), which exerts anti-inﬂammatory actions by
inhibiting leukocyte adhesion and platelet aggregation, and control-
ling vascular tone by signaling for the relaxation of adjacent vascular
smooth muscle cells [1]. The homeostatic properties of the endothe-
lium are also dependent on its function as a continuous, semiperme-
able barrier that tightly regulates the passage of nutrients,
macromolecules, ﬂuid, and cells between the blood and the inter-
stitial space [2,3]. Inﬂammatory vascular diseases such as athero-
sclerosis are characterized by endothelial dysfunction manifested as
a reduction in the bioactivity of endothelial-derived NO [1] and a loss
of endothelial barrier integrity leading to endothelial hyperperme-
ability [4,5]. Enhanced vascular oxidative stress during inﬂammation
is implicated as a principal cause of compromised endothelial NO
signaling [1] and barrier function [2,3] and accordingly there is
signiﬁcant interest in understanding the oxidative reactions involved.
Considerable clinical and experimental evidence supports that
myeloperoxidase (MPO), an oxidant-generating heme enzyme
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role in impairing the signaling and vasodilatory function of
endothelium-derived NO during inﬂammatory vascular disease.
Thus, circulating MPO levels are elevated in patients with cardiovas-
cular disease and the extent of this increase is an independent
predictor of the incidence of endothelial dysfunction manifested as
impaired endothelium-dependent vasorelaxation [6,7], as well as the
prevalence and degree of coronary artery disease and clinical event
risk in patients with acute coronary syndromes [8,9]. Inﬂammatory
stimuli that increase circulating MPO levels promote endothelial
dysfunction in healthy animals and humans, with a deﬁciency in
functional MPO conferring protection [10,11]. Circulating MPO
rapidly leaves the circulating compartment by binding to and
transcytosing the endothelium [12–15], resulting in its accumulation
within the subendothelial matrix, where it is anatomically positioned
to impair the signaling and vasodilatory function of endothelium-
derived NO by acting as a NO oxidase [10,13,16,17].
Subendothelial-localized MPO is not only positioned to interfere
with NO signaling, but also to generate reactive oxidants capable of
altering the structure and function of extracellular matrix proteins
[13,18–20]. The potent chlorinating agent hypochlorous acid (HOCl)
is the principal oxidant produced by MPO and is generated by
oxidation of chloride ions (Cl-) in the presence of the cosubstrate
hydrogen peroxide (H2O2) [21,22]. Thiocyanate (SCN
) and nitrite
(NO2
) are also signiﬁcant physiological substrates that divert the
enzyme from HOCl production to the generation of the thiol-
reactive oxidant hypothiocyanous acid (HOSCN) and the nitrating
radical nitrogen dioxide (NO2), respectively [22]. Previous studies
identify that subendothelial matrix proteins are signiﬁcant targets
for modiﬁcation by MPO-derived oxidants. Thus, MPO transcytosed
by cultured endothelial cells binds to the adhesive matrix substrate
ﬁbronectin, conferring speciﬁcity of MPO-catalyzed tyrosine nitra-
tion to this protein [13]. In atherosclerotic coronary arteries and
other inﬂamed vascular tissue from humans, MPO is characteristi-
cally found deposited within the subendothelium where it coloca-
lizes with ﬁbronectin-containing extracellular matrix and tyrosine-
nitrated proteins [23]. Extracellular deposits of MPO and HOCl-
modiﬁed proteins are similarly detected within the vascular
endothelium of human atherosclerotic arteries [24–26].
While oxidative modiﬁcation of subendothelial matrix proteins
by MPO-derived oxidants is a characteristic event during inﬂamma-
tory vascular disease, the implications of this process for endothelial
cell morphology and signaling are largely unknown. In the current
study, we show that endothelial-transcytosed MPO utilizes low
micromolar levels of H2O2 to mediate HOCl-dependent subendothe-
lial matrix oxidation, involving covalent cross-linking of ﬁbronectin,
and that this triggers cell–matrix de-adhesion driven by actomyosin-
dependent tensile stress. We provide evidence that endothelial de-
adhesion in response to HOCl-mediated matrix oxidation drives
changes in key adhesion-dependent signaling processes, with this
constituting a novel ‘‘outside-in’’ mode of redox signaling. Moreover,
diversion of MPO from HOCl production by SCN or NO2
 attenuates
de-adhesion and associated signaling responses, despite the latter
substrate supporting MPO-catalyzed matrix nitration. The ability of
transcytosed MPO to disrupt endothelial integrity and alter signaling
by targeted, HOCl-mediated subendothelial matrix oxidation may
have important implications for the regulation of endothelial func-
tion during vascular inﬂammation.Materials and methods
Cell culture
Bovine aortic endothelial cells (ECs, Lonza; passages 4–9) were
cultured in EBM2 medium with all supplements added excepthydrocortisone (EGM medium; Lonza) and routinely passaged on
gelatin-coated tissue culture ﬂasks.Cell experiments
For experiments with ECs containing transcytosed MPO, ECs
were initially cultured to conﬂuence in EGM medium on gelatin
(Sigma; coated at 100 mg/ml in PBS, 20 min, 22 1C). Conﬂuent EC
monolayers were then incubated for 2 h with 20 nM puriﬁed
human neutrophil MPO (Merck Millipore) in Hanks balanced salt
solution (HBSS) supplemented with 0.2% BSA, culture conditions
that permit maximal endothelial transcytosis of MPO [13,14]. ECs
containing transcytosed MPO were washed to remove unincor-
porated enzyme and then incubated in HBSS in the absence or
presence of relevant reaction components including 1 mM
methionine (Met), 100 mM 4-aminobenzoic acid hydrazide
(ABAH), 100 mM SCN , and/or 100 mM NO2 for 15 min, or with
cell signaling inhibitors (20 mM PP2, 40 mM blebbistatin, 10 mM
Y-27632) for 30 min, prior to treatment with H2O2 (2–50 mM) for
up to 1 h. In some experiments, cells were treated with reagent
HOCl added as a bolus. H2O2 and HOCl solutions were prepared
immediately before use and stock concentrations were deter-
mined spectrophotometrically (H2O2, e240 43.6 M1 cm1; HOCl,
e292 350 M1 cm1 at pH 12). For oxidant treatments, volumes
were selected to ensure uniformity of oxidant exposure expressed
relative to the adhesion area of cells (i.e., 1 ml for 12-well plates,
80 ml for 96-well plates).
For experiments with ECs adhered to ﬁbronectin as the sole
adhesive substrate, surfaces were ﬁrst coated with bovine ﬁbro-
nectin (Sigma; 5 mg/ml, 22.7 nM in PBS, 2 h, 37 1C) and then
blocked with BSA (0.2% in PBS, 0.5 h, 37 1C) prior to seeding of
cells in serum-free media (medium-199 containing 1% BSA; 1 ml
at 5105 cells/ml in 12-well plates, 200 ml at 2.5105 cells/ml in
96-well plates). These cell seeding densities yielded a near-
conﬂuent layer of adherent cells within 2 h. In experiments to
examine a role for ﬁbronectin-bound MPO on EC adhesion, MPO
was ﬁrst bound to ﬁbronectin-coated surfaces (20 nM MPO in
HBSS, 0.5 h, 37 1C, with subsequent washing) prior to the seeding
of cells. For surface binding of proteins, volumes were selected to
ensure uniformity of protein coating, expressed relative to the
adhesion area of cells (i.e., mg protein/mm2; 1 ml for 12-well
plates, 80 ml for 96-well plates). ECs adhered to ﬁbronectin or
MPO-bearing ﬁbronectin-coated surfaces were then subjected to
experimental treatments in the same manner as described above
for ECs containing transcytosed MPO.
For experiments to measure the propensity of ECs to adhere to
ﬁbronectin previously treated with MPO-derived oxidants, cell-free
surfaces with MPO-bearing ﬁbronectin were ﬁrst treated with H2O2
in the absence or presence of other reaction components in the
same manner as MPO-containing ECs (see above). Surfaces were
then incubated with Met (10 mM) for 10 min to quench residual
reactive, surface-bound protein chloramines formed by HOCl,
followed by washing, seeding of ECs, and measurement of cell
adhesion by cell substrate impedance.Experiments with puriﬁed ﬁbronectin
Puriﬁed bovine ﬁbronectin (100 nM, Sigma; twice desalted on
PD MiniTrap G-25 columns, GE Healthcare) in HBSS was oxidized
by pre-incubation with MPO (100 nM) for 15 min and exposure to
H2O2 (2–50 mM) for 1 h in the absence and presence of 1 mMMet,
100 mM ABAH, 100 mM SCN , or 100 mM NO2 .
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Cell–substrate impedance at the surface of 96-well gold micro-
electrode arrays (E-plate 96, Roche), expressed as ‘‘cell index’’, a
dimensionless value proportional to the area of cell–substrate
contact [27], was measured continuously following seeding of ECs
and subsequent treatments by an xCelligence system (Roche).
During measurements, electrode arrays were housed in an incuba-
tor port maintained at 37 1C with 5% CO2 saturation. The relative
number of attached ECs on electrode surfaces was quantiﬁed by
crystal violet staining, as previously detailed [20].
Live cell imaging
Differential interference contrast images of live cells on gela-
tin- or ﬁbronectin-coated 35-mm glass-bottomed culture dishes
(Fluorodish, World Precision Instruments) were recorded at 37 1C
on a heated stage at 5-s intervals using a 63x water objective on aFig. 1. Endothelial-transcytosed MPO colocalizes with matrix ﬁbronectin and mediat
(20 nM) for 2 h and unincorporated MPO was removed by washing. MPO-containing ECs
prior to H2O2 treatment were ﬁxed and imaged by laser confocal ﬂuorescence microsco
exposed to MPO displayed negligible immunoﬂuorescence staining for MPO (data not
measured by assaying cell supernatants by the Amplex Red assay at the indicated times.
to control cells. (C) MPO-containing ECs treated with H2O2 were ﬁxed and imaged b
protein (HOCl ox. protein; green) and MPO (red). In (A) and (C), images represent basola
of nuclei (blue); bars¼50 mm.Leica TCS SP5 microscope. The projected area of randomly
selected cells was quantiﬁed by manually tracing the membrane
edge and quantifying the number of enclosed pixels using ImageJ
software (NIH). Change in area of individual cells over time was
ﬁtted to a single exponential decay using nonlinear regression
(least squares ﬁtting; Prism 5, GraphPad Software) to determine
the half-life of cell contraction.
Measurement of H2O2
Cellular metabolism of exogenously added H2O2 was mea-
sured using an Amplex Red kit according to the manufacturer’s
instructions (Molecular Probes).
Western blotting
Following experiments, cell proteins and puriﬁed proteins were
immediately harvested into reducing loading buffer (50 mM Tris-HCl,es HOCl-dependent protein oxidation. EC monolayers were incubated with MPO
were then incubated with H2O2 (50 mM) for a further 1 h. (A) MPO-containing ECs
py using antibodies against ﬁbronectin (FN; green) and MPO (red); control ECs not
shown). (B) H2O2 consumption by control and MPO-containing ECs over 1 h was
Data represent the mean7SEM, n¼3 independent experiments, **Po0.01 relative
y laser confocal ﬂuorescence microscopy using antibodies against HOCl-oxidized
teral cell sections (upper panels) and merged side-on views showing DAPI staining
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bromophenol blue). Proteins were separated on 3–8% Tris/acetate
NuPAGE gels or 10% Bis/Tris NuPAGE gels (Invitrogen), electroblotted
to nitrocellulose (iBlot, Invitrogen), and then probed with mouse
monoclonal antibodies against ﬁbronectin (1:2000; clone E3E, Milli-
pore), HOCl-oxidized protein (1:25; cell supernatant, clone 2D10G9,
which does not cross-react with epitopes generated by oxidative
reactions involving nitrating species, transition metals or lipid per-
oxidation reactions [28]), Src (1:1000; BD Biosciences), paxillin
(1:1000: Cell Signaling), FAK (1:1000; Cell Signaling), and phospho-
FAK Tyr-397 (1:1000; BD Biosciences) or with rabbit polyclonal
antibodies against MPO (1:1000; Millipore), 3-nitrotyrosine
(1:1000; Millipore), tubulin (1:1000; Sigma), phospho-paxillin Tyr-
118 (1:1000; Cell Signaling), phospho-Src Tyr-416 (1:1000; Cell
Signaling), phospho-Src Tyr-527 (1:1000; Cell Signaling), myosin light
chain II (MLC-2) (1:1000; Cell Signaling), and diphospho-MLC-2 Thr-
18/Ser-19 (1:1000; Cell Signaling). Proteins were visualized on
membranes by horseradish peroxidase-conjugated secondary anti-
mouse or anti-rabbit antibodies (Cell Signaling) and enhanced
chemiluminescence detection (Amersham). Proteins were visualized
in gels by SyproRuby staining (Invitrogen) and a Fuji FLA-5000
imaging system.Immunoﬂuorescence
Cells on glass coverslips were processed for immunostaining
by ﬁxing with 4% paraformaldehyde (22 1C, 20 min) and quench-
ing free aldehydes with NH4Cl (50 mM) for 5 min prior to washingFig. 2. Endothelial-transcytosed MPO oxidatively cross-links matrix ﬁbronectin in a HO
2 h and unincorporated MPO was removed by washing. Control (MPO-free) and MPO
presence of Met (1 mM) or ABAH (100 mM). In (A), control ECs were also treated with a
preincubated with MPO (100 nM) for 15 min prior to addition of H2O2 (0–50 mM) and
(100 mM). (A, B) Cell proteins and (C, D) puriﬁed proteins were analyzed by Western b
(FN) or HOCl-oxidized protein (HOCl ox. protein). In (A), tubulin (55 kDa) was used
visualized in the gels by Syproruby staining (i.e., native FN monomer detected at 250 k
reduced by 50% on the vertical scale.in PBS. Cells were immunostained using mouse monoclonal
antibodies against ﬁbronectin (1:100), HOCl-oxidized protein
(clone 2D10G9) (1:50), and paxillin (1:1000) or a rabbit poly-
clonal antibody against MPO (1:300). Cyanine 2-conjugated goat
anti-mouse (green) and cyanine 3-conjugated donkey anti-rabbit
(red) antibodies were employed as secondary antibodies. Cell
nuclei were stained with DAPI (1:2000) and F-actin was stained
with Alexa 555-phalloidin (Invitrogen; 1:500). After washing with
PBS, cells were mounted in Elvanol (Mowiol 4–88, Hoechst,
Frankfurt, Germany). Laser confocal ﬂuorescence images were
recorded at room temperature using a 63x oil objective on a Leica
TCS SP5 microscope. Reconstructions of confocal images were
rendered using Imaris software.
Statistics
Statistical analyses were performed using one-way ANOVA
with Newman Keul’s post hoc testing with Prism 5 software.
Statistical signiﬁcance was accepted for P values o0.05.Results
Endothelial-transcytosed MPO oxidatively cross-links ﬁbronectin in a
HOCl-dependent manner
Incubation of conﬂuent monolayers of ECs with MPO resulted in
its uptake and accumulation within the subendothelial compart-
ment, where it colocalized with matrix ﬁbronectin (Fig. 1A),Cl-dependent manner. (A, B) EC monolayers were incubated with MPO (20 nM) for
-containing ECs were treated with H2O2 (1–50 mM) for 1 h in the absence and
bolus of reagent HOCl (10 mM) for 1 h. (C, D) Puriﬁed ﬁbronectin (FN; 100 nM) was
incubation for a further 1 h in the absence and presence of Met (1 mM) or ABAH
lotting (3–8% gels) under reducing conditions using antibodies against ﬁbronectin
as a protein loading control. In (C), protein bands of the puriﬁed proteins were
Da and MPO a-chain monomer detected at 60 kDa). Western blot/gel images are
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Control ECs not incubated with MPO displayed negligible immuno-
ﬂuorescence when probed with the antibody for MPO (data not
shown). ECs containing transcytosed MPO consumed exogenously
added H2O2 at signiﬁcantly enhanced rates compared to control
cells (Fig. 1B). Laser confocal microscopy and immunoﬂuorescence
showed that H2O2 consumption by MPO-containing ECs was
accompanied by the formation of HOCl-oxidized protein, detected
by the antibody clone 2D10G9 [28], which localized primarily
within the subendothelium and displayed colocalization with
MPO (Fig. 1C). Western blot analysis of protein extracts from ECs
containing transcytosed MPO and exposed to low micromolar
concentrations of H2O2 revealed extensive ﬁbronectin cross-linking,
reﬂected by loss of the parent ﬁbronectin band and generation of
non-reducible, high molecular weight (4250 kDa) protein aggre-
gates that were recognized by antibodies directed against ﬁbronec-
tin and HOCl-oxidized protein (Fig. 2A). The extent of ﬁbronectin
oxidation was dependent on H2O2 dose (Fig. 2A) and the concen-
tration of MPO added (Supplementary Fig. 1A). HOCl-oxidized
proteins and ﬁbronectin oxidation/cross-linking were not detected
in ECs treated with H2O2 alone or in MPO-containing ECs prior to
H2O2 treatment (Fig. 2A, Supplementary Figs. 1B and C). Puriﬁed
ﬁbronectin was similarly converted into HOCl-oxidized, highFig. 3. Thiocyanate and nitrite suppress HOCl-mediated ﬁbronectin oxidation by endot
for 2 h and unincorporated MPO was removed by washing. Control and MPO-containin
SCN (100 mM), NO2 (100 mM), or Met (1 mM). (C, D) Puriﬁed ﬁbronectin (FN; 100 nM)
for 1 h in the absence and presence of SCN (100 mM), NO2 (100 mM), or Met (1 mM).
(3–8% gels) using antibodies against FN, HOCl-oxidized protein (HOCl ox. protein), o
vertical scale.molecular weight aggregates by exposure to MPO in the presence
of H2O2 (Fig. 2C), consistent with previous observations by Vissers
and Winterbourn that puriﬁed ﬁbronectin can be oxidatively cross-
linked by MPO-derived HOCl [29]. Notably, extensive ﬁbronectin
cross-linking occurred when MPO-containing cells were exposed to
as little as 5 mMH2O2 (Fig. 2A). Inclusion of the MPO inhibitor ABAH
or the HOCl-scavenger methionine (Met) inhibited ﬁbronectin
cross-linking and generation of HOCl-oxidized protein within cells
(Fig. 2B) and with puriﬁed ﬁbronectin (Fig. 2D), observations that
identify MPO-derived HOCl as the damaging oxidant. Notably, HOCl
derived from low micromolar concentrations of H2O2 (10 mM) by
endothelial-transcytosedMPO efﬁciently oxidized matrix ﬁbronectin,
as judged by the loss of the parent ﬁbronectin band, while equivalent
doses of reagent HOCl added as a bolus to the apical endothelial
surface were ineffective (Fig. 2A). These data establish that transcy-
tosed MPO mediates targeted matrix oxidation by producing HOCl
focally within the subendothelial compartment.
Thiocyanate and nitrite suppress HOCl-mediated ﬁbronectin
oxidation by endothelial-transcytosed MPO
SCN and NO2
 are signiﬁcant physiological MPO substrates
that divert the enzyme from HOCl production to the generation ofhelial-transcytosed MPO. (A, B) EC monolayers were incubated with MPO (20 nM)
g ECs were then treated with H2O2 (50 mM) for 1 h in the absence and presence of
was incubated with MPO (100 nM) for 15 min and then treated with H2O2 (50 mM)
(A, B) Cell proteins and (C, D) puriﬁed proteins were analyzed by Western blotting
r 3-nitrotyrosine (NO2Tyr). Western blot/gel images are reduced by 50% in the
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the halogenation activity of MPO and acts to stimulate MPO
turnover [30]. While NO2
 is also metabolized by the peroxidase
activity of MPO it slows enzyme turnover by promoting MPO
Compound II accumulation [31]. In line with their expected
effects on MPO catalytic turnover, SCN accelerated and NO2

attenuated H2O2 consumption by ECs containing transcytosed
MPO, with H2O2 completely consumed within 1 h after oxidant
addition for all treatment conditions (Supplementary Fig. 2). After
1 h treatment, cell proteins were analyzed by Western blotting.
SCN supplementation was found to inhibit MPO-catalyzed
formation of HOCl-oxidized protein and ﬁbronectin modiﬁca-
tion/cross-linking in ECs (Fig. 3A) and with puriﬁed ﬁbronectin
(Fig. 3C). NO2
 also blocked the formation of HOCl-oxidized
protein, attenuated ﬁbronectin modiﬁcation/cross-linking, and
promoted the generation of 3-nitrotyrosine, detected on high
molecular weight protein aggregates, both in ECs (Fig. 3A) and
with puriﬁed ﬁbronectin (Fig. 3C). To differentiate the potential
roles of HOCl and NO2 in mediating ﬁbronectin cross-linking in
the presence of NO2
 , we examined the effect of including Met,
which scavenges HOCl but not NO2 [32]. Inclusion of Met
strongly suppressed ﬁbronectin cross-linking and caused a sub-
stantial proportion of 3-nitrotyrosine reactive protein to shift
from high molecular weight aggregated material to a single band
that comigrated with the parent ﬁbronectin band, both in ECs
(Fig. 3B) and with puriﬁed ﬁbronectin (Fig. 3D). This reveals that
endothelial-transcytosed MPO simultaneously promotes covalent
cross-linking and nitration of matrix ﬁbronectin in the presence
of NO2
 , and that HOCl is the oxidant primarily responsible for
mediating ﬁbronectin cross-linking.
MPO disrupts the cell-adhesive function of puriﬁed ﬁbronectin in a
HOCl-dependent manner
We next addressed the functional consequences of ﬁbronectin
oxidation by MPO, measured by its ability to support EC attach-
ment and spreading. In these studies, MPO was ﬁrst bound to
ﬁbronectin-coated surfaces and unbound MPO was removed by
washing before initiating oxidant production by the ﬁbronectin-
bound MPO by exposure to H2O2 for 30 min. EC attachment and
spreading on native and MPO-oxidized ﬁbronectin was then
measured in real time using a cell–substrate impedance electrode.
ECs seeded on native ﬁbronectin in serum-free media were
fully attached and spread within 2 h (Fig. 4A). Cell–substrate
impedance values in fully adhered cells, quantiﬁed as ‘‘cell index’’Fig. 4. MPO-derived HOCl impairs the cell-adhesive function of ﬁbronectin. Fibronectin w
unboundMPO was removed by washing. Control (MPO-free) and MPO-bearing ﬁbronectin
of Met (1 mM), ABAH (100 mM), SCN (100 mM), or NO2 (100 mM). Surfaces were trea
surfaces washed before seeding ECs and measurement of EC adhesion and spreading by
bearing ﬁbronectin (‘‘MPO’’), without pre-treatment with H2O2. (B) EC adhesion (2 h po
absence and presence of Met or ABAH. (C) EC adhesion (2 h post-seeding) onMPO-bearing
and/or Met. Data represent the mean7SEM, n¼3. ***Po0.001 relative to EC adhesion o(a value proportional to the area of cell–matrix contact [27]),
correlated linearly with cell number and increased with the
density of ﬁbronectin coating (r20 mg/ml) (Supplementary
Fig. 3). Background EC adhesion levels on surfaces without
ﬁbronectin were negligible (Supplementary Fig. 3), conﬁrming
that adhesion under these conditions was dependent on this
substrate.
Binding of MPO (20 nM) to approximately equimolar concen-
trations of ﬁbronectin (coated at 5 mg/ml/ 22 nM) prior to cell
seeding did not alter the rate or extent of cell attachment and
spreading, establishing that MPO binding does not mask ﬁbro-
nectin motifs that support EC adhesion (Fig. 4A). Pretreatment of
the MPO-bearing ﬁbronectin with low micromolar doses of H2O2
(r10 mM) markedly impaired the ability of ﬁbronectin to support
subsequent EC attachment and spreading, with this loss of
adhesive function abrogated by scavenging HOCl with Met and
inhibiting MPO with ABAH (Fig. 4B). The MPO-dependent impair-
ment of ﬁbronectin’s cell adhesive function was also blocked by
inclusion of SCN or partially attenuated by NO2
 (Fig. 4C). In
reactions with NO2
 , HOCl scavenging by Met completely pre-
served the cell adhesive function of ﬁbronectin (Fig. 4C), despite
the ability of MPO to catalyze tyrosine nitration of ﬁbronectin
under these reaction conditions (Figs. 3C and D). These ﬁndings
establish that oxidative modiﬁcation/cross-linking of ﬁbronectin
by MPO-derived HOCl disrupts its cell adhesive function and that
suppression of HOCl-mediated oxidative modiﬁcation by SCN
and NO2
 protects against this loss of function.
Subendothelial MPO induces EC de-adhesion in a HOCl-dependent
manner
Having established that MPO-derived HOCl disrupts the cell
adhesive function of ﬁbronectin (Fig. 4) and that ﬁbronectin is an
important target for HOCl produced by subendothelial MPO
(Figs. 1 and 2), we next examined the capacity of endothelial-
transcytosed MPO to alter established EC cell–matrix adhesion. To
more speciﬁcally address the potential role of ﬁbronectin oxidation
by subendothelial-localized MPO in altering EC cell–matrix adhe-
sion, we performed equivalent studies with ECs adhered on
ﬁbronectin as the sole adhesive substrate. In these studies, MPO
was ﬁrst incorporated directly onto ﬁbronectin-coated surfaces (as
detailed in Fig. 4) and ECs were allowed to fully adhere for 42 h (cf.
Fig. 4A) before treatment with H2O2 to initiate subcellular oxidant
production by the ﬁbronectin-bound MPO. Changes in cell–matrix
adhesion elicited by oxidant production within ECs by transcytosedas coated at 5 mg/ml (ca. 22 nM) and incubated with MPO (20 nM) for 30 min and
surfaces were then treated with H2O2 (1–10 mM) for 1 h in the absence and presence
ted with Met (10 mM, 10 min) to quench residual protein-bound chloramines and
cell–substrate impedance. (A) EC adhesion (0–2 h post-seeding) on control or MPO-
st-seeding) on control and MPO-bearing ﬁbronectin pre-treated with H2O2 in the
ﬁbronectin (‘‘MPO’’) pretreated with H2O2 in the absence and presence of SCN
 , NO2

n MPO-bearing ﬁbronectin without H2O2 treatment. # Po0.05.
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substrate impedance biosensor.
In ECs adhered on MPO-bearing ﬁbronectin, H2O2 exposure
provoked a rapid, time-dependent (Fig. 5A; Po0.001 relative to
control cells at 2 min after addition of 10 mM H2O2) and dose-
dependent (Fig. 5B) loss in cell–matrix contact. Quantiﬁcation of ECs
adhered to impedance electrodes by crystal violet staining revealed
that this decrease in cell–matrix contact was independent of changes
to the number of attached cells (Supplementary Fig. 4A). ECs not only
maintained cell attachment but remained viable during oxidant
treatment, revealed by their ability to reestablish adhesion to control
levels following the addition of fresh media (Supplementary Fig. 4B).
A similarly rapid loss of cell–matrix contact in response to H2O2
exposure was recapitulated in ECs containing transcytosed MPO
(Fig. 6A). No loss of adhesion was detected in ECs exposed to
equivalent doses of H2O2 in the absence of MPO (Figs. 5A and 6A).
Live cell imaging of MPO-containing ECs exposed to H2O2 by
differential interference contrast microscopy showed that the losses
in cell–matrix contact were due to rapid membrane retraction and
‘‘rounding up’’ of cells (i.e., ‘‘de-adhesion’’) and conﬁrmed that all
cells remained attached to the substratum (ECs adhered on MPO-Fig. 5. Subendothelial MPO induces EC de-adhesion from ﬁbronectin in a HOCl-depende
(20 nM) for 30 min and unbound MPO was removed by washing. ECs were seeded and a
(2 h post-seeding; cf. Fig. 4A) before exposure to H2O2 (1–10 mM) in the absence and pre
in cell adhesion upon exposure to H2O2 were measured by cell–substrate impedance; c
which was given a value of 1. (A) Cell adhesion in ECs pre-adhered on control or MPO-b
of ECs pre-adhered on control or MPO-bearing ﬁbronectin (‘‘MPO’’) 30 min following ex
pre-adhered on MPO-bearing ﬁbronectin (‘‘MPO’’) 30 min following exposure to H2O
mean7SEM, (A) n¼6 or (B, C) n¼3. *Po0.05, **Po0.01, and ***Po0.001 relative to c
Fig. 6. Endothelial-transcytosed MPO induces EC de-adhesion in a HOCl-dependent man
MPO was removed by washing. Control (MPO-free) and MPO-containing ECs were then
(100 mM), or NO2 (100 mM). Changes in cell adhesion upon exposure to H2O2 were mea
value at the time of H2O2 addition, which was given a value of 1. (A) Cell adhesion
adhesion of MPO-containing ECs 30 min following treatment with H2O2 in the absence o
*** Po0.001 relative to MPO-containing ECs without H2O2 exposure. # Po0.05. (C) Fr
movie (Supplementary Movie 2) of MPO-containing ECs before (0 min) and after treatbearing ﬁbronectin—Supplementary Movie 1; ECs containing trans-
cytosed MPO—Supplementary Movie 2, with representative frames
at 0 and 2min after H2O2 exposure shown in Fig. 6C).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.freeradbiomed.2012.10.002.
Supplementation of ECs adhered on MPO-bearing ﬁbronectin
with Met or ABAH (Fig. 5B) and SCN or NO2
 (Fig. 5C) prior
to H2O2 exposure attenuated MPO-mediated de-adhesion. The
residual de-adhesion observed in the presence of SCN and NO2

was completely prevented by scavenging spurious amounts of
HOCl with Met (Fig. 5C). Inclusion of Met and SCN alone or
NO2
 and Met in combination, also completely abrogated de-
adhesion in ECs containing transcytosed MPO and treated with
H2O2 (Fig. 6B).
Overall, these data establish that subendothelial-localized
MPO triggers cell–matrix de-adhesion in a HOCl-dependent
manner, and support that this involves disruption of the cell-
adhesive function of ﬁbronectin. Moreover, they identify that
SCN and NO2
 attenuate MPO-induced de-adhesion in accor-
dance with their capacity to suppress HOCl-mediated ﬁbronectin
oxidation (Fig. 3).nt manner. Fibronectin was coated at 5 mg/ml (ca. 22 nM) and incubated with MPO
llowed to fully adhere on control (MPO-free) and MPO-bearing ﬁbronectin surfaces
sence of Met (1 mM), ABAH (100 mM), SCN (100 mM), or NO2 (100 mM). Changes
ell index data are normalized to the cell index value at the time of H2O2 addition,
earing ﬁbronectin (‘‘MPO’’) 0–30 min following exposure to H2O2. (B) Cell adhesion
posure to H2O2 in the absence or presence of Met or ABAH. (C) Cell adhesion in ECs
2 in the absence or presence of SCN
 , NO2
 , and NO2
/Met. Data represent the
ell adhesion changes of MPO-containing ECs without H2O2 treatment. # Po0.05.
ner. EC monolayers were incubated with MPO (20 nM) for 2 h and unincorporated
treated with H2O2 (5 or 25 mM) in the absence and presence of Met (1 mM), SCN
sured by cell–substrate impedance; cell index data are normalized to the cell index
of control or MPO-containing ECs 0–30 min following exposure to H2O2. (B) Cell
r presence of Met, SCN , NO2
 , or Met/NO2
 . Data represent the mean7SEM, n¼6.
ames from a representative live cell differential interference contrast microscopy
ment with H2O2 (10 mM) for 2 min. Bar¼50 mm.
Fig. 7. Endothelial-transcytosed MPO alters the phosphorylation of paxillin, Src, and MLC-2 in a HOCl-dependent manner. (A–E) EC monolayers were incubated with MPO
(20 nM) for 2 h and unincorporated MPO was removed by washing. Control (MPO-free) and MPO-containing ECs were then treated with H2O2 (2–25 mM) in the absence or
presence of other reaction components (1 mM Met, 100 mM ABAH, 100 mM SCN-, or 100 mM NO2) or selective inhibitors of myosin II (blebbistatin, 40 mM), Rho kinase (Y-
27632, 10 mM), or Src kinase (PP2, 20 mM). At the indicated times after the addition of H2O2, cellular protein extracts were prepared and analyzed by Western blotting for
the levels of ﬁbronectin (FN), paxillin Tyr-118 phosphorylation, paxillin, Src Tyr-416 or Tyr-527 phosphorylation, Src, FAK Tyr-397 phosphorylation, FAK, MLC-2 Tyr-18/
Ser-19 diphosphorylation, and MLC-2.
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dependent changes in focal adhesion and cytoskeletal signaling
Cell–matrix adhesion involves the assembly of membrane
domains called focal adhesions that coordinate cellular responses to
local changes in the chemical and physical state of the extracellular
matrix by transducing ‘‘outside-in’’ signaling [33,34]. Phosphorylation
of the focal adhesion protein paxillin at Tyr-118 has emerged as a
major mechanobiological signaling ‘‘switch’’ that regulates responses
to changes in cell–matrix adhesion, with loss of force transduction
between the cell membrane and the underlying matrix up-regulating
paxillin phosphorylation at this amino acid site [35]. Also, phosphor-
ylation of myosin light chain II (MLC-2) at Thr-18 and Ser-19, which
positively regulates actomyosin contractility, plays a central role in
the remodeling of the cytoskeleton and adhesive contacts in response
to external stimuli [35,36]. Therefore, we next investigated the extent
to which matrix oxidation and disruption of cell–matrix adhesion by
endothelial-localized MPO was linked with changes in the phosphor-
ylation status of paxillin and MLC-2.
Exposure of MPO-containing ECs to H2O2 at Z10 mM triggered
a time-dependent increase in the phosphorylation of paxillin at
Tyr-118 that was apparent after 2 min oxidant addition and
maintained up until 15 min before returning to baseline levels
at 30 min (Fig. 7A and B). Interestingly, exposure of MPO-
containing ECs to lower H2O2 doses (5 mM), where EC adhesion
was largely maintained (Fig. 6A), resulted in a time-dependent
decrease in paxillin Tyr-118 phosphorylation (Fig. 7B). No altera-
tion in paxillin phosphorylation was observed in control ECs
exposed to equivalent doses of H2O2 in the absence of MPO
(Fig. 7A). The dose-dependent modulation of paxillin phosphor-
ylation by MPO (i.e., down-regulation at low oxidant dose or up-
regulation at higher oxidant dose) was prevented by Met and
suppressed in the presence of SCN and NO2
 plus Met (Fig. 7C),identifying HOCl as the primary signaling oxidant produced by
EC-localized MPO.
Tyr-118 of paxillin is a phosphorylation target for FAK or Src
kinase [37]. In MPO-containing ECs exposed to H2O2, while no
marked change in Tyr-397 phosphorylated and hence activated
FAK was apparent (Fig. 7A), exposure of these cells to 25 mM H2O2
resulted in the time-dependent increase in phosphorylation of Src
at its activation/auto-phosphorylation site Tyr-416 that paralleled
the time-dependent increase in paxillin Tyr-118 phosphorylation
(Fig. 7A and B). Activation of Src by Tyr-416 phosphorylation can
involve dephosphorylation of an inhibitory phosphorylation site
(Tyr-527) [38]. Src Tyr-416 phosphorylation and paxillin Tyr-118
phosphorylation in MPO-containing ECs exposed to 25 mM H2O2
were not initially linked with Src Tyr-527 dephosphorylation;
however, decreases in Tyr-527 phosphorylation were observed
after 15–30 min (Fig. 7B). Src Tyr-416 phosphorylation and Tyr-
527 dephosphorylation were both prevented by Met and sup-
pressed in the presence of SCN or NO2
 plus Met (Fig. 7C). A role
of Src kinase for HOCl-dependent paxillin phosphorylation was
indicated by the ability of the Src kinase inhibitor PP2 to block
both basal and MPO-induced paxillin Tyr-118 phosphorylation
(Fig. 7D).
With respect to myosin II signaling, exposure of MPO-
containing ECs to H2O2 resulted in the dose- (Fig. 7A) and
time-dependent (Fig. 7B) increase in the cellular levels of
diphosphorylated MLC-2 (Tyr-18/Ser-19). MPO-induced MLC-2
phosphorylation was inhibited by addition of Met, SCN-, or NO2

plus Met (Fig. 7C), conﬁrming its dependence on HOCl, and was
prevented by inhibiting Rho kinase with Y-27632 (Fig. 7E). Y-
27632 did not suppress HOCl-mediated ﬁbronectin oxidation,
conﬁrming that its activity reﬂected its action as a Rho kinase
inhibitor and not by suppressing production of or damage by
HOCl (Fig. 7E).
Fig. 8. EC de-adhesion induced by endothelial-transcytosed MPO involves myosin II-mediated contractility. EC monolayers were incubated with MPO (20 nM) for 2 h and
unincorporated MPO was removed by washing. MPO-containing ECs were then treated with H2O2 (10 mM) for 15 min in the absence or presence of inhibitors of myosin II
(blebbistatin, 40 mM), Rho kinase (Y-27632, 10 mM), or Src kinase (PP2, 20 mM). Changes in cell adhesion upon exposure to H2O2 were measured by cell–substrate
impedance and changes in projected cell area (‘‘cell area’’) were measured by image analysis of time-lapse differential interference contrast microscopy movies. (A, B) Cell
adhesion of MPO-containing ECs 0–15 min (15 min in panel B) following exposure to H2O2 in the absence or presence of blebbistatin, Y-27632, or PP2. Data represent the
mean7SEM, n¼6. Cell index data are normalized to the cell index value at the time of H2O2 addition, which was given a value of 1. (C, D) Cell area of MPO-containing ECs
0–13 min following exposure to H2O2 in the absence or presence of blebbistatin (n¼10 cells, 2 replicate movies, 5 randomly selected cells per movie; cf. Supplementary
Movies 2 and 4); cell area data are normalized to the cell area value at the time of H2O2 addition, which was given a value of 1. (C, inset) Cell contraction half-life as
determined by ﬁtting the decrease in the area of individual cells to a single exponential decay. (D) Cell area before (0 min) and 13 min following exposure to H2O2.
***Po0.001 relative to MPO-containing ECs without exposure to H2O2. # Po0.05.
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The preceding studies identify that HOCl produced by
subendothelial-localized MPO modulates Src-dependent paxillin
phosphorylation and elicits Rho kinase-dependent MLC-2 phos-
phorylation, which signals for increased myosin II-dependent
contractility. We next examined the potential functional role of
these signaling events in MPO-induced de-adhesion by selectively
inhibiting myosin II signaling and Src-dependent paxillin phos-
phorylation. Changes in EC adhesion were quantiﬁed over time by
cell–substrate impedance and/or by measuring decreases in the
projected area of individual cells by image analysis of time-lapse
differential interference contrast movies.
Inhibition of Src with PP2 had no material impact on MPO-
induced MLC2 phosphorylation (Fig. 7E) and de-adhesion
(Fig. 8B), indicating that while Src-dependent paxillin phos-
phorylation is a signaling response linked with endothelial de-
adhesion, it does not directly contribute to this process. In
contrast, inhibition of myosin II motor function with blebbista-
tin markedly abrogated MPO-induced membrane retraction
from the substratum and from adjacent cells in ECs containing
transcytosed MPO (Fig. 8A–D) and in ECs adhered on MPO-bearingﬁbronectin (Supplementary Figs. 5A–D) (see also Supplementary
Movies 1–4 for representative time-lapse differential interference
contrast movies used for image analysis). Blebbistatin prevented
EC de-adhesion without inhibiting HOCl-mediated ﬁbronectin
oxidation or MLC-2 phosphorylation (Fig. 7E), conﬁrming that its
inhibitory activity reﬂected its action as an inhibitor of myosin II
motor function.
The rates of membrane retraction in individual cells during
MPO-induced de-adhesion (measured as decreases in the pro-
jected cell area over time) were quite uniform, with losses in cell
area plateauing at ca. 50% of initial values and cells exhibiting
average contraction half-lives of ca. 1–2 min both in ECs contain-
ing transcytosed MPO (Fig. 8C and D) and in ECs adhered on MPO-
bearing ﬁbronectin (Supplementary Figs. 5C and D). Of note,
robust increases in Rho kinase-dependent MLC-2 phosphorylation
occurred after 5 min, when membrane retraction was already
extensive (Fig. 7B). Furthermore, while Rho kinase inhibition with
Y-27632 did not suppress the initial rapid phase of MPO-induced
de-adhesion (i.e., o5 min following H2O2 exposure) it was
inhibitory during the subsequent phase of de-adhesion (i.e.,
45 min following H2O2 exposure) (Fig. 8A and B), a time period
when Rho kinase-dependent MLC-2 phosphorylation was mark-
edly increased (Fig. 7B).
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exposure (Supplementary Fig. 6A) and 10 min following H2O2
exposure (Supplementary Fig. 6B) showed that de-adhesion
involved extensive inward remodeling of the actin cytoskeleton
and accumulation of F-actin at the membrane periphery, which
was abrogated by scavenging HOCl with Met (Supplementary
Fig. 6C). Notably, paxillin also accumulated at the membrane
periphery during HOCl-mediated de-adhesion in association with
F-actin (Supplementary Figs. 6A–C). Although Rho kinase-
dependent MLC-2 phosphorylation peaked within 5–15 min fol-
lowing H2O2 exposure (Fig. 7B), this was not accompanied by an
increase in long actin stress ﬁbers and instead de-adhesion was
characterized by a loss of preexisting stress ﬁbers (Supplementary
Figs. 6A and B).
Overall, these ﬁndings support that while up-regulation of Rho
kinase-dependent contractility contributes to the overall extent of
MPO-induced de-adhesion, the initial rapid phase of membrane
retraction represents a response to oxidative disruption of cell–
matrix contacts by MPO-derived HOCl, and is primarily driven by
preexisting stress in the actin cytoskeleton.Discussion
During vascular inﬂammation, MPO is released from circulat-
ing leukocytes and accumulates within the subendothelial extra-
cellular matrix by binding to and transcytosing the endothelium
[13,23]. Compelling clinical and experimental evidence has iden-
tiﬁed endothelial-transcytosed MPO as a key mediator of
impaired NO signaling in inﬂammatory vascular disorders and
in human cardiovascular disease, with this thought to reﬂect its
ability to efﬁciently intercept and oxidatively consume
endothelial-derived NO within the subendothelial space
[7,10,11]. However, subendothelial-localized MPO is also anato-
mically positioned to impact on endothelial morphology and
signaling by oxidatively modifying the structure and function of
adhesive extracellular matrix proteins [13,19,20].
This study has shown for the ﬁrst time that MPO transcytosed
by ECs utilizes low micromolar concentrations of H2O2 to mediate
targeted, HOCl-dependent oxidation of the subendothelial matrix,
and that this involves covalent modiﬁcation/cross-linking of
ﬁbronectin. Employing real-time cell–substrate impedance bio-
sensor measurements and quantitative live cell image analysis,
we showed that HOCl-mediated oxidation of the subendothelial
matrix triggers rapid retraction of the cell membrane from the
substratum and from adjacent ECs (de-adhesion). EC de-adhesion
was linked with the activation of Src and modulation of Tyr-118
phosphorylation of paxillin, a key focal adhesion-dependent
signaling process, as well as Rho kinase-dependent MLC-2 phos-
phorylation. Notably, de-adhesion dynamics were dependent on
the contractile state of cells, with inhibition of myosin II and Rho
kinase-mediated MLC-2 phosphorylation signiﬁcantly retarding
the rate of membrane retraction.
Importantly, these rapid de-adhesion and signaling responses
were absent in ECs treated with H2O2 alone in the absence of
MPO. While other studies identify that H2O2 can alter cell–cell/
cell–matrix adhesion and focal adhesion/cytoskeletal signaling
(e.g., paxillin phosphorylation, MLC-2 phosphorylation) in ECs,
signiﬁcantly higher oxidant doses (Z100 mM H2O2) are typically
required to elicit robust morphological and signaling responses
[39,40]. Moreover, instead of eliciting de-adhesion as we observed
in MPO-containing ECs, treatment with H2O2 alone enhances cell–
matrix adhesion in ECs in a concentration-dependent manner
[39]. Our data therefore highlight that EC-transcytosed MPO
signiﬁcantly potentiates, and alters, the signaling actions of
H2O2 by converting it to HOCl.Previous studies have shown that transcytosed MPO associates
basolaterally with ﬁbronectin and locally catabolizes NO2
 to the
nitrating radical NO2, conferring speciﬁcity of MPO-mediated
protein tyrosine nitration to ﬁbronectin [13]. Immunohistochem-
ical studies support that ﬁbronectin is an important target for
MPO-derived NO2 in inﬂammatory vascular disorders, with MPO,
ﬁbronectin, and tyrosine-nitrated proteins colocalizing within
diseased human vessels [23]. However, the functional implica-
tions of NO2 production and resultant protein nitration of
ﬁbronectin within the subendothelium by MPO are largely
unknown. The current study reveals that in the presence of
NO2
 subendothelial MPO concomitantly catalyzes HOCl-
dependent cross-linking and tyrosine nitration of matrix ﬁbro-
nectin. However, HOCl-mediated reactions were shown to be
primarily responsible for triggering EC de-adhesion and asso-
ciated cell signaling events; selective scavenging of HOCl with
Met markedly attenuated ﬁbronectin cross-linking, de-adhesion,
and cell signaling responses, but did not prevent ﬁbronectin
nitration.
Another biologically important MPO substrate is SCN , which
is derived primarily from dietary sources (e.g., broccoli) and is
elevated in smokers. Currently, there is considerable interest in
whether diversion of MPO from HOCl production by SCN to
instead produce the thiol-reactive oxidant HOSCN is protective or
deleterious in the context of inﬂammatory vascular conditions
[41,42]. SCN strongly suppressed HOCl production by EC-
localized MPO, reﬂecting its action as a competitive inhibitor of
HOCl production (indicated by its ability to stimulate H2O2
metabolism) and also likely reﬂecting its ability to rapidly
scavenge HOCl, with both of these processes yielding HOSCN
[30,43]. We found that SCN protected against MPO-induced EC
de-adhesion and associated signaling responses, indicating that
these processes are insensitive to HOSCN production by EC-
localized MPO. These ﬁndings are in line with other studies that
identify a protective, antioxidant function for SCN against MPO-
mediated cellular injury [41].
Model studies employing puriﬁed ﬁbronectin as the sole
adhesive substrate provided strong evidence that induction of
EC de-adhesion by MPO-derived HOCl involves disruption of the
cell-adhesive function of ﬁbronectin. Thus, prior oxidation of
ﬁbronectin by MPO-derived HOCl readily impaired its ability to
support EC attachment and spreading, and this loss in function
correlated with the capacity of HOCl, produced at the basolateral
surface of ECs by ﬁbronectin-bound MPO, to disrupt established
EC adhesion on ﬁbronectin. In accordance with their ability to
inhibit HOCl-mediated ﬁbronectin modiﬁcation/cross-linking,
SCN and NO2
 suppressed MPO-induced impairment of attach-
ment and spreading of ECs on, and de-adhesion of ECs from,
ﬁbronectin.
While our data identify a causal role for HOCl-mediated
matrix oxidation in triggering EC de-adhesion, we show that
actomyosin tensile forces signiﬁcantly accelerate this process.
Thus, the rate of de-adhesion triggered by H2O2 exposure in
MPO-containing ECs was markedly attenuated by the inhibition
of myosin II motor function with blebbistatin. Up-regulation of
Rho kinase-dependent contractility contributed to the MPO-
induced EC de-adhesion, but not during the initial rapid phase
of membrane retraction, which preceded robust increases in
Rho kinase-dependent MLC-2 phosphorylation and was not
attenuated by Rho kinase inhibition.
Our data support a model where subendothelial-localized
MPO catalyzes targeted, HOCl-mediated matrix oxidation that
disrupts adhesive forces at the cell–matrix interface to trigger
membrane retraction driven by pre-existing tensile force within
the actin cytoskeleton (Scheme 1A and B). Notably, recent studies
identify that targeted disruption of cell–matrix contacts by
Scheme 1. Proposed model of MPO-induced EC de-adhesion and ‘‘outside-in’’ redox signaling. (A) MPO binds to the subendothelial matrix and mediates targeted HOCl-
dependent matrix oxidation that (B) disrupts cell–matrix contact, leading to (C) membrane retraction driven by unopposed tension in the actin cytoskeleton and alteration
of adhesion-dependent signaling. pax, paxillin.
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driven by preexisting actomyosin tensile stress [44].
As well as mechanically coupling the actin cytoskeleton to the
subendothelial matrix, adhesive contacts are enriched in cyto-
plasmic signaling proteins and rapidly transduce mechanical
signals provided by changes in cell–matrix adhesion into intra-
cellular phosphorylation events. This ‘‘outside-in’’ signaling, in
which paxillin phosphorylation plays a central regulatory role,
allows cells to respond rapidly and sensitively to chemical and
physical changes in the extracellular matrix and engages signal-
ing networks that control cell shape, motility, proliferation, and
survival [33–36].
We propose that the local disruption of cell–matrix contacts by
HOCl in the subendothelium drives signaling changes by altering
cell–matrix mechanotransduction (Scheme 1C). Paxillin Tyr-118
phosphorylation is negatively regulated by force transduction
between the actin cytoskeleton and the underlying matrix at focal
adhesions (i.e., cell–matrix traction) [35]. We show that F-actin and
paxillin are extensively remodeled during HOCl-induced de-adhe-
sion and the increase in paxillin Tyr-118 phosphorylation observed
at higher oxidant doses (i.e., Z10 mM) is consistent with a global
loss in cell–matrix traction. Phosphorylation of paxillin at Tyr-118
generates docking sites for SH2 domain containing proteins [34]
and engages signaling networks that regulate the assembly of new
adhesive contacts [35]. Notably, at lower oxidant doses, where
matrix oxidation and de-adhesion were less extensive, the levels of
paxillin phosphorylation were initially maintained and subse-
quently down-regulated, consistent with a compensatory increase
in cell–matrix traction at pre-existing and/or newly formed adhe-
sive contacts. Importantly, very low oxidant doses (5 mM) were
required to induce extensive ﬁbronectin cross-linking and changes
in paxillin phosphorylation (Fig. 2A, Fig. 7C).
Another important novel aspect of this work is the ﬁnding that
HOCl produced subendothelially by MPO induces Rho kinase-
dependent MLC-2 diphosphorylation at Tyr-18 and Ser-19 and
Src activation, as indexed by Tyr-416 phosphorylation and Tyr-
527 dephosphorylation. Together with alterations in paxillin phos-
phorylation, MLC-2 phosphorylation and Src activation represent
key signaling processes involved in adhesion responses [35,36]. The
speciﬁcity of these responses to the action of MPO-derived HOCl
indicates that they may be functionally linked to changes in cell–
matrix mechanotransduction (see discussion below). Notably, pre-
vious studies identify that loss of cell adhesion alone can trigger
increases in Src activation and paxillin phosphorylation [45,46].
Signiﬁcantly, no previous study has addressed the possibility
that oxidants might drive changes in cell signaling by altering
cell–matrix mechanotransduction. Our proposed model of ‘‘out-
side-in’’ redox signaling (Scheme 1) differs from the conven-
tional model of redox signaling in that it involves oxidantsmodifying extracellular proteins and generating mechanical
signals to propagate intracellular phosphorylation events
instead of directly modifying and altering the activity of intra-
cellular signaling proteins.
We do not exclude that ‘‘conventional’’ redox signaling
mechanisms contribute to the signaling responses elicited by
subendothelial-localized MPO. HOCl could contribute to the
observed signaling responses by directly oxidizing critical
cysteine thiol residues present on RhoA (which activates Rho
kinase) and Src, leading to their activation [38,47,48], or by
oxidizing active site cysteine thiols in regulatory protein phos-
phatases [1]. However, if the observed signaling responses were
primarily driven by oxidation of intracellular protein thiols, the
diversion of MPO from HOCl production by SCN would also be
expected to be stimulatory, not inhibitory as observed, given
that HOSCN is a more thiol-selective oxidant than HOCl [22].
Furthermore, kinetic considerations of oxidant reactivity support
that HOCl exerts its biological actions by oxidizing targets within
a very short distance of its site of production [49]. In line with
this prediction, our current data identify that HOCl produced
extracellularly by endothelial-transcytosed MPO mediates focal
oxidation of matrix proteins within the subendothelial compart-
ment to alter cellular adhesion and adhesion-dependent signal-
ing. We propose that this involves HOCl-mediated impairment of
the cell-adhesion (integrin- and/or heparin-binding) motifs of
ﬁbronectin. The lack of cysteine and tyrosine residues in these
adhesion motifs, and hence their resistance to functional
damage by HOSCN and NO2, could explain why diversion of
MPO from HOCl production by SCN and NO2
 protects against
MPO-induced de-adhesion and associated signaling responses.
Physiological redox signaling processes are increasingly recog-
nized to be highly regulated, involving targeted, oxidative mod-
iﬁcation of speciﬁc proteins, with signaling speciﬁcity achieved
through spatial association of oxidant-generating enzymes and
target proteins within speciﬁc cellular compartments [1,50].
Interestingly, the alteration of endothelial signaling by suben-
dothelial matrix-bound MPO ﬁts within this paradigm. It is
therefore tempting to speculate that the delivery of MPO to the
subendothelial compartment by endothelial-transcytosis to pro-
mote HOCl-mediated matrix oxidation might serve an unforseen
regulatory function during inﬂammatory vascular responses.
However, its potential pathophysiological signiﬁcance is clear:
our present ﬁndings identify that matrix oxidation resulting
from the production of low, physiological ﬂuxes of HOCl by
subendothelial-localized MPO triggers a rapid loss in endothelial
cell–matrix adhesion and promotes membrane retraction, events
that will signiﬁcantly perturb the integrity of the endothelium.
These processes could play a key pathological role in inﬂam-
matory vascular conditions by promoting tissue edema and
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of the endothelium by exposing intimal proteins.Acknowledgments
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